You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 160 No. 7, April 10, 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (77)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Mortality Among Women With Ductal Carcinoma In Situ of the Breast in the Population-Based Surveillance, Epidemiology and End Results Program

Virginia L. Ernster, PhD; John Barclay, MS; Karla Kerlikowske, MD; Heather Wilkie, BA; Rachel Ballard-Barbash, MD

Arch Intern Med. 2000;160:953-958.

Background  Over 14% of breast cancers diagnosed in the United States annually are ductal carcinomas in situ (DCIS). There are no published population-based reports of the likelihood of breast cancer death among US women with DCIS.

Methods  We used data from the Surveillance, Epidemiology and End Results program to determine the likelihood of breast cancer death at 5 and 10 years among US women aged 40 and older diagnosed with DCIS from 1978 to 1983 (before screening mammography was common; n=1525) and from 1984 to 1989 (when screening mammography became common; n=5547). We also calculated standardized mortality ratios (SMRs) to compare observed deaths from breast cancer, cardiovascular disease, and all causes combined among women with DCIS with deaths expected based on general population mortality rates.

Results  Among women diagnosed with DCIS from 1978 to 1983, 1.5% died of breast cancer within 5 years and 3.4% within 10 years. Among women diagnosed from 1984 to 1989, 0.7% died of breast cancer within 5 years and 1.9% within 10 years. Relative to the general population, risk of breast cancer death was greater for women diagnosed from 1978 to 1983 (SMR, 3.4; 95% confidence interval [CI], 2.5-4.5) than for women diagnosed from 1984 to 1989 (10-year SMR, 1.9; 95% CI, 1.5-2.3). Women diagnosed from 1984 to 1989 were significantly less likely than women in the general population to have died of cardiovascular diseases (10-year SMR, 0.6; 95% CI, 0.5-0.7) or of all causes combined (SMR, 0.8; 95% CI, 0.7-0.8).

Conclusions  Among women diagnosed with DCIS, risk of death from breast cancer was low, at least within the 10 years following diagnosis. This may reflect the effectiveness of treatment for DCIS, the "benign" nature of DCIS, or both. At 10 years, women diagnosed from 1984 to 1989 were less likely than women diagnosed from 1978 to 1983 to have died of breast cancer, and their risk of dying of all causes combined was lower than that in the general population.


From the Department of Epidemiology and Biostatistics, School of Medicine, University of California (Drs Ernster and Kerlikowske, Mr Barclay, and Ms Wilkie), and the General Internal Medicine Section, Department of Veterans Affairs (Dr Kerlikowske), San Francisco, Calif; and the Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Md (Dr Ballard-Barbash).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hanging in the Balance: Making Decisions About the Benefits and Harms of Breast Cancer Screening Among the Oldest Old Without a Safety Net of Scientific Evidence
Mandelblatt and Silliman
JCO 2009;27:487-490.
FULL TEXT  

Molecular Grading of Ductal Carcinoma In situ of the Breast
Balleine et al.
Clin. Cancer Res. 2008;14:8244-8252.
ABSTRACT | FULL TEXT  

Factors Associated with Lymph Node Assessment in Ductal Carcinoma in situ: Analysis of 1988-2002 Seer Data
Porembka et al.
Ann. Surg. Oncol. 2008;15:2709-2719.
ABSTRACT | FULL TEXT  

Breast Cancer Screening in BRCA1 Mutation Carriers: Effectiveness of MR Imaging--Markov Monte Carlo Decision Analysis
Lee et al.
Radiology 2008;246:763-771.
ABSTRACT | FULL TEXT  

Oral Contraceptive Use and Risk of Breast Carcinoma In situ
Nichols et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:2262-2268.
ABSTRACT | FULL TEXT  

Results of 23,810 Cases of Ductal Carcinoma-in-situ
Sumner et al.
Ann. Surg. Oncol. 2007;14:1638-1643.
ABSTRACT | FULL TEXT  

Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians
Armstrong et al.
ANN INTERN MED 2007;146:516-526.
ABSTRACT | FULL TEXT  

Effectiveness of radiation therapy in older women with ductal carcinoma in situ.
Smith et al.
JNCI J Natl Cancer Inst 2006;98:1302-1310.
ABSTRACT | FULL TEXT  

Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853--A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group
Bijker et al.
JCO 2006;24:3381-3387.
ABSTRACT | FULL TEXT  

Absence of HER4 Expression Predicts Recurrence of Ductal Carcinoma In situ of the Breast
Barnes et al.
Clin. Cancer Res. 2005;11:2163-2168.
ABSTRACT | FULL TEXT  

Mammographic Density and Breast Cancer After Ductal Carcinoma In Situ
Habel et al.
JNCI J Natl Cancer Inst 2004;96:1467-1472.
ABSTRACT | FULL TEXT  

Ductal Carcinoma in Situ of the Breast
Burstein et al.
NEJM 2004;350:1430-1441.
FULL TEXT  

Trends in the Treatment of Ductal Carcinoma In Situ of the Breast
Baxter et al.
JNCI J Natl Cancer Inst 2004;96:443-448.
ABSTRACT | FULL TEXT  

Loss of Aurora A/STK15/BTAK Overexpression Correlates with Transition of in Situ to Invasive Ductal Carcinoma of the Breast
Hoque et al.
Cancer Epidemiol. Biomarkers Prev. 2003;12:1518-1522.
ABSTRACT | FULL TEXT  

Characteristics Associated With Recurrence Among Women With Ductal Carcinoma In Situ Treated by Lumpectomy
Kerlikowske et al.
JNCI J Natl Cancer Inst 2003;95:1692-1702.
ABSTRACT | FULL TEXT  

Mammographic Screening for Breast Cancer
Fletcher and Elmore
NEJM 2003;348:1672-1680.
FULL TEXT  

The Clinical Significance of Cytokeratin-Positive Cells in Lymph Nodes at the Time of Mastectomy From Patients With Ductal Carcinoma-In-Situ
Tamhane et al.
Ann. Surg. Oncol. 2002;9:999-1003.
ABSTRACT | FULL TEXT  

Will Screening Mammography in the East Do More Harm than Good?
Leung et al.
Am. J. Public Health 2002;92:1841-1846.
ABSTRACT | FULL TEXT  

Detection of Ductal Carcinoma In Situ in Women Undergoing Screening Mammography
Ernster et al.
JNCI J Natl Cancer Inst 2002;94:1546-1554.
ABSTRACT | FULL TEXT  

Microcalcifications in Breast Tissue Phantoms Visualized with Acoustic Resonance Coupled with Power Doppler US: Initial Observations
Weinstein et al.
Radiology 2002;224:265-269.
ABSTRACT | FULL TEXT  

HER-2/neu Gene Amplification in Ductal Carcinoma In Situ of the Breast
Hoque et al.
Cancer Epidemiol. Biomarkers Prev. 2002;11:587-590.
ABSTRACT | FULL TEXT  

The Social Context of Science: Cancer and the Environment
Davis and Webster
The ANNALS of the American Academy of Political and Social Science 2002;584:13-34.
ABSTRACT  

Women's attitudes to false positive mammography results
Godby et al.
BMJ 2000;321:1409-1409.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.